Northwestern Mutual Wealth Management CO Protagonist Therapeutics, Inc Transaction History
Northwestern Mutual Wealth Management CO
- $112 Billion
- Q3 2024
A detailed history of Northwestern Mutual Wealth Management CO transactions in Protagonist Therapeutics, Inc stock. As of the latest transaction made, Northwestern Mutual Wealth Management CO holds 78,894 shares of PTGX stock, worth $2.93 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
78,894
Previous 157,788
50.0%
Holding current value
$2.93 Million
Previous $5.47 Million
35.16%
% of portfolio
0.0%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding PTGX
# of Institutions
245Shares Held
56.8MCall Options Held
71.7KPut Options Held
114K-
Farallon Capital Management LLC San Francisco, CA5.86MShares$218 Million1.32% of portfolio
-
Black Rock Inc. New York, NY5.76MShares$214 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY5.43MShares$202 Million3.89% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.22MShares$157 Million0.0% of portfolio
-
State Street Corp Boston, MA3.18MShares$118 Million0.01% of portfolio
About Protagonist Therapeutics, Inc
- Ticker PTGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,084,100
- Market Cap $1.83B
- Description
- Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...